Delivery Order SPE2DR25D3014-SPE2DR26FP1KF
- Not listed
- The Defense Logistics Agency awarded a $1,101.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg. This contract, with an ultimate completion date of November 7, 2025, was awarded competitively with no set-aside designation. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,259.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium delayed-release 40 milligram tablets. The award is non-set-aside and carries an ultimate completion date of December 8, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a $3,604.57 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg. This competitive delivery order, which is set to be completed by September 18, 2025, represents a firm fixed-price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium 40 mg delayed-release tablets, valued at $2,562.72. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 16, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,133.16 to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium delayed-release 40 mg tablets (1,000 count) with a completion date of October 16, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The award represents a single transaction within AmerisourceBergen's broader relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,786.98 to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in quantities of 1,000 units. This is a firm fixed-price contract with no set-aside designation, reflecting a competitively awarded transaction. The delivery order was executed on October 17, 2025, with an ultimate completion date of October 20, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.78 to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium delayed-release 40 mg tablets (1,000 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance executed from the contractor's Conshohocken, Pennsylvania facility and completion scheduled for November 18, 2025. The award represents a single delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in quantities of 90 tablets. This competitively awarded, non-set-aside contract carries a ceiling value of $1,472.72 and is classified as a firm fixed price delivery order with an ultimate completion date of December 11, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium delayed-release 40 mg tablets (1,000 count) under a firm fixed-price contract valued at $4,422.64. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025. This delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, valued at $2,108.69. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under open competition. The contract is set to be completed by October 22, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania....
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1KFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,128.43 to AmerisourceBergen Drug Corp for 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg on December 18, 2025, with completion expected by December 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility. The order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems worldwide. The Pantoprazole order exemplifies the routine pharmaceutical procurement that flows through this strategic vehicle, which enables the company to supply medications across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/17/25 |